Is Madison MSGE stock worth including in a portfolio Madison reports 176 EPS miss on cost pressure Estrella Immunopharma ESLA Stock Changing Trend Institutional Selling 20260427 AGMB AgomAb outlines key upcoming clinical trial milestones in its newly released quarterly earnings report What currency exposure Beacon Fin BBT Q4 2025 Earnings Fall Short What emerging products Boston SAM Q3 2000 EPS Misses Views NDSN Nordson Corporation posts narrow Q1 2026 EPS miss shares rise slightly on unchanged investor outlook GPOR Gulfport narrowly misses Q4 2025 EPS estimates shares dip 056 percent amid mild negative investor sentiment